HomeBenign or Pathogenic? Assessing Genetic Variants Using “Precision Humanization” of Small Animal Models – A White Paper

The age of genomic and precision medicine is revolutionizing medical practices, but it is also revealing gaps in our knowledge of genetics. Each individual’s genome harbors a significant number of unique alleles that may impact the individual’s health in unpredictable ways. These are the clinical Variants of Uncertain (or Unknown) Significance (VUS). How do the physician and clinical geneticist make decisions in this noisy background when trying to determine whether the gene mutation seen in the patient is benign or pathogenic? Are there alternative approaches to assess clinical variants to uncover the treatment options that lead to better patient outcomes?

Complete the form below to download your copy today.

[vfb id=10]

Scroll to Top